Where does Radux Devices, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Radux Devices, LLC ranks #15,568 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Radux Devices, LLC hold?

Radux Devices, LLC holds 19 US utility patents granted between 2017 and 2025, spanning 4 technology areas.

What is Radux Devices, LLC's Innovation Score?

Radux Devices, LLC has an Innovation Score of 38.3 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Radux Devices, LLC focus on?

Radux Devices, LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 12 patents. Grants appear in 4 CPC subclasses total.

Is Radux Devices, LLC's patent grant rate increasing or decreasing?

Radux Devices, LLC's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Radux Devices, LLC's patents?

Radux Devices, LLC's patents average 19.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Radux Devices, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Radux Devices, LLC

USPTO PatentsView assignee record - 19 granted patents across 4 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Radux ranks #15,568 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 4 technology areas.

#15,568
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.3/100): 19.9
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15568 · US Corporation #15,568 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 19 grants
MID-PACK #15,568/49,997
PHOTO-FINISH R H Tamlyn & Sons
CPC-NARROW A61B · 4 areas
INNOV-THIN 38.3/100
CLAIMS-RICH 19.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: R. H. Tamlyn & Sons, LP (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Radux Devices · this assignee

38
3D Lighting… · lowest

7

What this shows Radux's Innovation Score is 38.3/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Radux's grants concentrate

Radux Devices, LLC is a focused PatentsView assignee: 4 CPC subclasses with 63.2% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2017. By volume, Radux sits between R. H. Tamlyn & Sons, LP and Recargo, Inc..

Radux's three-year grant acceleration

Radux Devices, LLC shows 8 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

R H Tamlyn & Sons

19
Rich IP Technology

19
RTI Surgical

19
Radiant(Guangzhou…

19
Rapyuta Robotics

19
Razer Auto

19
Realtime Data

19
Recargo

19
Radux Devices ◀

19

What this shows Radux holds 19 patents at rank #15,566, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Radux

By rank, the assignees closest to #15,566 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Radux's primary technology class.

Radux's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Radux Devices, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	5.3%
2018	3	15.8%
2019	2	10.5%
2020	3	15.8%
2021	1	5.3%
2022	4	21.1%
2023	2	10.5%
2024	2	10.5%
2025partial year	1	5.3%

Which technologies does Radux Devices, LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 12

G21F - Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor 12

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 7

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 6

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#15,568

of 49,997 tracked assignees

Innovation Score

38.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Radux Devices, LLC's patent record in context - here's where to go next.

Radux Devices, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 63.2% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #15,568 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Radux Devices, LLC against R. H. Tamlyn & Sons, LP, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.